Comparison of MR images and histochemical localization of intra-arterially administered microglia surrounding β-amyloid deposits in the rat brain

Histology and Histopathology

Volumn 21, Issue 7-9, 2006, Pages 705-711

  Song, Y ^a,c   Morikawa, S ^a   Morita, M ^a   Inubushi, T ^a   Takada, T ^a   Torii, R ^a   Kitamura, Y ^b   Taniguchi, T ^b   Tooyama, Ikuoo ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^c CHINA MEDICAL UNIVERSITY   (China)

Author keywords

amyloid; Alzheimer's disease; Microglia; MRI; Senile plaque

Indexed keywords

AMYLOID BETA PROTEIN; ENHANCED GREEN FLUORESCENT PROTEIN; SODIUM CHLORIDE; SUPERPARAMAGNETIC IRON OXIDE; GREEN FLUORESCENT PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LABELING; CELL TRANSPLANTATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIAGNOSTIC VALUE; HIPPOCAMPUS; HISTOPATHOLOGY; IMAGE ANALYSIS; IMAGE QUALITY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INTERMETHOD COMPARISON; MICROGLIA; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; ANIMAL; BRAIN; CELL LINE; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; MALE; METABOLISM; METHODOLOGY; MOUSE; TRANSPLANTATION; WISTAR RAT;

AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; CELL LINE; CELL TRANSPLANTATION; GREEN FLUORESCENT PROTEINS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICROGLIA; RATS; RATS, WISTAR;

EID: 33645768363     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Akiyama H. and McGeer P.L. (2004). Specificity of mechanisms for plaque removal after A beta immunotherapy for Alzheimer disease. Nat. Med. 10, 117-118.
2. Allport J.R. and Weissleder R. (2001). In vivo imaging of gene and cell therapies. Exp. Hematol. 29, 1237-1246.
3. Bard F., Cannon C., Barbour R., Burke R.L., Games D., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Lieberberg I., Motter R., Nguyen M., Soriano F., Vasquez N., Weiss K., Welch B., Seubert P., Schenk E. and Yednock T. (2000). Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer' s disease. Nat. Med. 6, 916-919.
4. Bulte J.W., Duncan I.D. and Frank J.A. (2002). In vivo magnetic resonance tracking of magnetically labeled cells after transplantation. J. Cereb. Blood Flow Metab. 22, 899-907.
5. Cagnin A., Brooks D.J., Kennedy A.M., Gunn R.N., Myers R., Turkheimer F.E., Jones T., Banati R.B. (2001). In-vivo measurement of activated microglia in dementia. Lancet 358, 461-467.
6. DiCarlo G., Wilcock D., Henderson D., Gordon M. and Morgan D. (2001). Intra-hippocampal LPS injections reduce Aβ load in APP + PS1 transgenic mice. Neurobiol. Aging 22, 1007-1012.
7. Hardy J.A. and Higgins G.A. (1992). Alzheimer's disease: the amyloid cascade hypothesis. Science 256, 184-185.
8. Hardy J. and Selkoe D.J. (2002). The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356.
9. Heckl S., Pipkorn R., Nagele T., Vogel U., Kuker W. and Voight K. (2004). Molecular imaging: Bridging the gap between neuoradiology and neurohistology. Histol. Histopathol. 19, 651-668.
10. Imai F., Sawada M., Suzuki H., Kiya N., Hayakawa M., Nagatsu T., Marunouchi T. and Kanno T. (1997). Migration activity of microglia and macrophages into rat brain. Neurosci. Lett. 237, 49-52.
11. Kaneda Y., Nakajima T., Nishikawa T., Yamamoto S., Ikegami H., Suzuki N., Nakamura H., Morishita R. and Kontani H. (2002). Hemagglutinating virus of Japan (HVJ) envelope vector as a versatile gene delivery system. Mol. Ther. 6, 219-226.
12. Marr R.A., Guan H., Rockenstein E., Kindy M., Gage F.H., Verma I. Masliah E. and Hersh L. B. (2004). Neprilysin regulates amyloid Beta peptide levels. J. Mol. Neurosci. 22, 5-11.
13. Matsuoka Y., Shao L., Debnath M., Lafrancois J., Becker A., Gray A., Aisen P., Mathis C., Klunk W. and Duff K. (2005). An Abeta sequestration approach using non-antibody Abeta binding agents. Curr. Alzheimer Res. 2, 265-268.
14. McGeer P.L. and McGeer E.G. (2001). Inflammation, autotoxicity and Alzheimer disease. Neurobiol. Aging 22, 799-809.
15. Niwa H., Yamamura K. and Miyazaki J. (1991). Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108, 193-199.
16. Sawada M., Imai F., Suzuki H., Hayakawa M., Kanno T. and Nagatsu T. (1998). Brain-specific gene expression by immortalized microglial cell-mediated gene transfer in the mammalian brain. FEBS Lett. 433, 37-40.
17. Schenk D.B. and Yednock T. (2002). The role of microglia in Alzheimer's disease: friend or foe? Neurobiol. Aging 23, 677-679.
18. Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Liao Z., Lieberburg I., Motter R., Mutter L., Soriano F., Shopp G., Vasquez N., Vandevert C., Walker S., Wogulis M., Yednock T., Games D. and Seubert P. (1999). Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400, 173-177.
19. Shimamura M., Morishita R., Endoh M., Oshima K., Aoki M., Waguri S., Uchiyama Y. and Kaneda Y. (2003). HVJ-E envelope vector for gene transfer into central nervous system. Biochem. Biophys. Res. Commun. 300, 464-471.
20. Takata K., Kitamura Y., Tsuchiya D., Kawasaki T., Taniguchi T. and Shimohama S. (2003). Heat shock protein-90-induced microglial clearance of exogenous amyloid-beta1-42 in rat hippocampus in vivo. Neurosci. Lett. 344, 87-90.
21. Toyoda K., Tooyama I., Kato M., Sato H., Morikawa S., Hisa Y. and Inubushi T. (2004). Effective magnetic labelling of transplanted cells with HVJ-E for magnetic resonance imaging. Neuroreport 15, 589-593.
22. Versijpt J.J., Dumont F., Van Laere K.J., Decoo D., Santens P., Audenaert K., Achten E., Slegers G., Dierckx R.A., Korf J. (2003). Assessment of neuroinflammation and microglial activation in Alzheimer's disease with radiolabelled PK11195 and single photon emission computed tomography. A pilot study. Eur. Neurol. 50, 39-47.
23. Wilcock D.M., DiCarlo G., Henderson D., Jackson J., Clarke K., Ugen K.E., Gordon M.N. and Morgan D. (2003). Intracranially administered anti-Abeta antibodies reduce beta-amyloid deposition by mechanisms both independent of and associated with microglial activation. J. Neurosci. 23, 3745-3751.
24. Wyss-Coray T., Lin C., Yan F., Yu G.Q., Rohde M., McConlogue L., Masliah E. and Mucke L. (2001). TGF-beta 1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat. Med. 7, 612-618.
25. Wyss-Coray T., Loike J.D., Brionne T.C., Lu E., Anankov R., Yan F., Silverstein S.C. and Husemann J. (2003). Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat. Med. 9, 453-457.